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Abstract 
BACKGROUND: With the establishment of laser photocoagulation as a standard treatment modality for 
prethreshold retinopathy of prematurity (ROP), a dramatic reduction of cases with ROP blindness and severe 
visual impairment have been reported. In the same time, high refractive errors, a common complication in ROP 
cases and especially in ROP treated infants, have become the main cause of visual and often severe visual 
impairment.  
AIM: The purpose of our study was to analyse the long-term refractive status in children at 3.5 years after laser-
treatment for type 1 prethreshold ROP. 
PATIENTS AND METHODS: A retrospective, one centre study of refractive status of 18 children with laser-
treated type 1 prethreshold ROP was conducted. The refraction after cycloplegia with 1% cyclopentolate was 
measured at a mean age of 3.56 years (SD ± 0.34). Hyperopia was subdivided into two groups – low hyperopia 
(SE < +5.0 D) and high hyperopia (SE ≥ +5.0 D). Myopia was classified as myopia (SE ≥ –0.25D) and high 
myopia (SE ≥ -5.0 D). Astigmatism was divided into low astigmatism (plus CD ≥ +1.0 D) and high astigmatism 
(plus CD ≥ +2.0 D). 
RESULTS: Thirty-three eyes of 18 children were recruited in the study. Three eyes were excluded because of 
unfavourable anatomical results. The mean gestational age at birth was 27.3 weeks (24-31 weeks, SD ± 1.78), 
and the mean birth weight – 928.9 g (550-1500 g, SD ± 252.8). The mean spherical equivalent for the whole 
group was -1.82 D and ranged from -9.00 D to +4.50 D (SD ± 3.48). Hyperopia was observed in 12 (36.4%) eyes. 
Myopic refraction had 21 (63.6%) eyes. Astigmatism was detected in 18 (54.5%) eyes. Anisometropia had 3 
(16.7%) children. Six children (33.4%) had strabismus (4 esotropia; 2 exotropia). 
CONCLUSION: High per cent of treated infants for vision-threatening ROP have visual significant refractive errors 
and strabismus that can cause serious visual impairment if not treated properly and on time. 
 
 
 
 
Introduction 
 
Retinopathy of prematurity (ROP) is a leading 
cause of avoidable childhood blindness and severe 
visual impairment worldwide [1]. Significant advances 
in neonatology and perinatal medicine in our country 
in recent years lead to the survival of more and more 
premature babies born with low and extremely low 
birth weight, making us contemporaries of the third 
ROP epidemic. According to the Bulgarian ROP 
screening guidelines, every prematurely born baby 
with birth weight (BW) less than 1500 grams and 
gestational age (GA) below 32 weeks must be 
screened, and all babies with type 1 prethreshold 
ROP must be treated preferably with diode laser 
photocoagulation [2]. Significant refractive errors and 
anisometropia are frequently associated findings in 
ROP patients, especially in treated children [3], [4], 
[5], [6]. Higher prevalence of high myopia in children 
treated with cryotherapy for threshold ROP is first 
discussed in CRYO-ROP study [4]. Later, Early 
Treatment for Retinopathy of Prematurity (ETROP) 
study reveals a higher prevalence of refractive errors 
(myopia, astigmatism) in treated premature babies 
than in spontaneously regressed ROP infants and 
mature children, nevertheless better anatomical and 
functional results in children treated for prethreshold 
ROP with laser coagulation compared to children 
treated for threshold ROP with cryoablation or laser 
therapy [5], [6]. 
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The purpose of our study was to analyze the 
long-term refractive status in children at 3.5 years 
after laser-treatment for type 1 prethreshold ROP. 
 
 
Patients and Methods 
 
Patients 
A retrospective, one centre study of refractive 
status of 18 children with laser-treated type 1 
prethreshold ROP was conducted. All infants were 
treated at Pediatric Eye Department, Eye Clinic, 
University Hospital "Alexandrovska", Medical 
University, Sofia, Bulgaria for the period August 2011 
– December 2013. All children were born prematurely 
with birth weight less than 1500 grams and gestational 
age below 32 weeks. Retinal changes before and 
regularly after treatment were documented with the 
RetCam imaging system (Clarity Medical Systems 
Inc., Pleasanton, CA, USA). All children were treated 
with transpupillary diode laser photocoagulation 
(Iridex Oculight SLx Tri-Mode 810nm Diode Laser®) 
by the same qualified pediatric ophthalmologist. The 
indications for treatment were prethreshold type 1 
ROP (zone I, any stage with plus disease; stage 3 
ROP in zone I with or without plus disease; stage 3 
ROP in zone II with the plus disease) and aggressive 
posterior ROP (AP-ROP). The laser was applied on 
the avascular retina without treatment of the present 
ridge or epiretinal fibrovascular proliferation. Eyes with 
unfavourable structural outcomes (posterior retinal 
detachment; retinal fold involving the macula; 
retrolental fibrous tissue) [4] were excluded from the 
study.  
 
 
Methods 
 
Refraction was measured by cycloplegic 
retinoscopy with spot retinoscope. A cycloplegia with 
1% cyclopentolate and regimen of 3 installations in 15 
minutes, and examination in 30 minutes after the third 
drop was performed. A conversion to the spherical 
equivalent (SE) was made for every eye for statistic 
reasons [7].  
Hyperopia was subdivided into two groups – 
low hyperopia (SE < +5.0 D) and high hyperopia (SE 
≥ +5.0 D). Myopia and astigmatism were defined 
using the ETROP trial definitions [5], [6] – myopia (SE 
≥ -0,25 D) and high myopia (SE ≥ –5.0 D); 
astigmatism (plus cylindrical degree (CD) ≥ +1.0 D) 
and high astigmatism (CD ≥ +2.0 D). Anisometropia 
was defined as a difference equal or more than 1.0 D 
for hyperopia and equal or more than 2.0 D for 
myopia. 
The data were analysed using the IBM SPSS 
20 software. For statistical purposes of the study, 
each eye of every infant was used independently. 
 
 
Results 
 
Eighteen children, but 33 eyes were 
conducted in the study. Three eyes were excluded for 
unfavourable anatomical results – total retinal 
detachment (1 eye) and retinal folds involving the 
macula (2 eyes).  
The mean age at the time of examination was 
3.56 years (range from 3 to 4 years; SD ± 0.34). Sex 
distribution was almost equal – 10 (55.6%) boys and 8 
(44.4%) girls. The mean gestational age at birth was 
27.3 weeks (24-31 weeks, SD ± 1.78), and the mean 
birth weight – 928.9 g (550-1500 g, SD ± 252.8). With 
extremely low birth weight (under 1000 g) were 13 
(72.2%) children and with very low birth weight (1000-
1500 g) – 5 (27.8%) children. Zone 2 ROP was 
observed in 23 (69.7%) eyes; Zone 1 ROP – 5 
(15.2%) eyes and AP-ROP – 5 (15.2%) eyes.  
Table 1: BW and GA characteristics in different studies 
Study/author Year Mean BW (g) Mean GA (weeks) 
Present study 2017 928.9 ± 252.8 27.3 ±1.78 
Stoica F et al [7] 2016 1363.4 ± 304.7 29.4 ± 1.96 
Nguyen PH et al [12] 2015 1426.4 29.8 
Katoch D et al [13] 2011 1121.7 ± 254.8 28.9 ± 2.03 
Roohipoor R et al [14] 2015 1441 ± 491 28.6 ± 3.2 
Axer-Siegel R et al [9] 2008 833 ± 250.3 26 ± 1.9 
ETROP [5,6] 2004
(2011;2013)
 703 25 
Yoon JM et al [11] 2017 646 ± 143 24.3 ± 1.1 
 
The mean spherical equivalent for the whole 
group was -1.82 D and ranged from -9.00 D to +4.50 
D (SD 3.48). Hyperopia was observed in 12 (36.4%) 
eyes – 10 (30.3%) eyes with low hyperopia and 2 
(6.1%) eyes with high hyperopia more than +5.00 D 
SE. Myopic refraction was observed in 21 (63.6%) 
eyes – myopia in 14 (42.4%) eyes and high myopia in 
7 (21.1%) eyes. Astigmatism was observed in 18 
(54.5%) eyes.  
Low astigmatism was measured in 12 (36.4%) 
eyes, and 6 (18.2%) eyes had high astigmatism. 
Anisometropia was observed in 3 (16.7%) children. 
Six (33.4%) children had strabismus (4 esotropia; 2 
exotropia). Three of the strabismic infants were with 
unfavourable structural results.  
Table 2: Myopia prevalence in different studies 
Study/author Myopia (%) High Myopia (%) 
Present study 63.6 21.1 
Nguen PH et al [12] 59.0 32.0 
Stoica F et al. [7] 70.8 30.2 
Axer-Siegel R et al. [9] 55.2 23.9 
Katoch D et al. [13] 26.1 1.4 
Kaur S et al. [26] 75 26.3 
Yang CS et al [25] 77.0 16.7 
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Discussion 
 
Bulgaria is a small country in South East 
Europe with a population of about 7 million people and 
the delivery rate of 9.2/1000. About 10.0% of all 
babies are prematurely born with birth weight less 
than 2500g. Mandatory ROP screening is conducted 
in almost all neonatal intensive care units of every 
baby born before 32 gestational weeks and with birth 
weight less than 1500 g [2], [8]. In different eye 
centres, different treatment modalities are used – 
cryotherapy, intravitreal anti-VEGF medications and 
diode laser photocoagulation [8]. Pediatric Unit of Eye 
Clinic, University Hospital "Alexandrovska", 
Department of Ophthalmology, Medical University, 
Sofia is the biggest centre in Bulgaria and here for a 
period of 5 years (August 2011 – December 2016) we 
had 54 children (102 eyes) treated for type 1 
prethreshold ROP with diode laser photocoagulation. 
According to our ROP guidelines for 
screening and treatment every prematurely born baby 
with BW < 1500 grams and GA < 32 weeks must be 
screened, and if type 1 prethreshold ROP is detected, 
it must be treated [2]. Different countries have 
different ROP criteria, according to their social and 
economic development and neonatal intensive unit 
care. High-income economies are focused mainly on 
babies with BW less than 1250 g [5], [9], while other 
countries have higher criteria – BW < 2000g and/or 
GA < 34 weeks [7], [10]. In our study, ROP treated 
children were with a mean birth weight of 928.9 g (SD 
± 252.8g) and meant gestational age of 27.3 weeks 
(SD ± 1.78w). They are higher than those reported by 
studies where ROP screening guidelines were BW < 
1250 g [5], [9] and lower than these discussed by 
many other authors with higher screening criteria [7], 
[11], [12], [13], [14].  
Laser photocoagulation of the avascular 
retina is the standard treatment modality for ROP and 
most countries worldwide have been adopted the 
ETROP study treatment criteria [5] and CRYO-ROP 
study criteria for unfavourable structural outcomes [4]. 
In our study we had unfavourable anatomical results 
in 3 (8.3%) eyes showing the high effectiveness of 
type 1 prethreshold ROP laser treatment compared to 
eyes treated at threshold [4], [5], [15]. 
We had a very high incidence of strabismus 
(33.4%), but half of the cases were in children with 
eyes with unfavourable structural results. If we 
exclude these 3 cases, the strabismus rate just in 
children with the favourable bilateral outcome will 
become 20.0%. These results are similar to the squint 
rate of ETROP study [16] and lower than data 
reported by Stoica et al., (46.15%) and Sahni et al., 
(50%) [7], [17]. Very low strabismus rate was found by 
Katoch et al., (8.3%) and Nguyen et al., (10%) [12], 
[13]. These big differences between different studies 
can be mainly explained with the different follow-up 
time, but all show that esotropia is the main type of 
strabismus. In our study, anisometropic amblyopia 
was the main risk factor for the treatable strabismic 
cases with our anisometropia prevalence of 16.7%. 
Nevertheless, this prevalence was very low compared 
to the results of Stoica et al., with their reported rate of 
55.7% [7].  
High prevalence of refractive errors, mainly 
myopia and high myopia are main functional 
disturbances not only in threshold [15], [18] but in 
prethreshold ROP laser treated infants [5], [6], [19], 
[20]. In our study the mean spherical equivalent for 
the whole group was -1.82 D, which is similar to the 
results of Kuo et al., (-1.71) [21], Lolas et al., (-1.75 D) 
[22] and Nguyen et al., (-2.87 D) [12]. Higher SE 
values than ours were reported in many other studies. 
Hwang CK et al. reported SE of -5.4 D [23]; Dhawan A 
et al., had SE of -4.71D [15]; Stoica F et al., found 
mean SE value of -4.12 D [7]. 
The most common refraction in our group was 
myopic. Shortsightedness had 63.6% of the eyes and 
21.1% of the eyes were with high myopia more than -
5 D. Myopia is very common in children with laser-
treated ROP (higher than those that can be found in 
mature children or premature children with no ROP or 
spontaneously regressed ROP) and vary significantly 
from 14% [24] to 77% [25]. 
In our study hyperopia was observed in 
36.4% eyes. Hyperopic rate varies significantly in 
different studies from 20% [26] to 86% [24], mainly 
depending on the follow-up duration of the study.  
Astigmatism had 54.6% of children, and 
18.2% had high astigmatism. Our astigmatic 
prevalence is similar to that reported by Marinov et al., 
after 7 years follow-up period – 59.0% [3] and lower 
than that reported by many authors [7,10] and 
especially by Yang et al., [25] with their rate of 98% 
astigmatism rate.  
Our study has several limitations. The main 
limitation is the sample size – 33 eyes of 18 children. 
The group was small limiting the power of the findings, 
but have its objective explanations: 1) relatively small 
number of premature babies and premature babies 
with ROP that must be treated because of the small 
population and negative demographic situation in our 
country; 2) one centre study; 3) the limited infant age 
of examination – just children between 3 and 4 years. 
Other limitations of this study are the lack of a control 
group, short follow-up period and retrospective 
character. 
In conclusion, diode laser photocoagulation is 
the established treatment modality for prethreshold 
ROP in Bulgaria in recent years with better anatomical 
and functional results than cryotherapy [2]. 
Nevertheless, a high per cent of treated infants have 
visually significant refractive errors and strabismus 
that can cause serious visual impairment if not treated 
properly and on time. This reveals the need for 
obligatory long-term follow-up examinations of all 
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prematurely born babies and especially ROP treated 
infants. 
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